Produkte
65 Suchergebnisse
Quick actions | ISIN | Basisw. | Produkt | Richtung | SL | Ref. | Geldkurs | Geld/Briefspanne | Briefkurs | Bezugsv. | % Tag | % Woche | % Monat | Emissionstag |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis Mini Future mit ISIN code: CH1427973172 | Novartis | Mini Future | Short | 100.98 | 95 | 0.89 | 0.080 | 0.97 | 10 | -1.11% | -8.25% | -27.05% | 12 März 2025 | |
Novartis Mini Future mit ISIN code: CH1442962366 | Novartis | Mini Future | Short | 100 | 95 | 0.4 | 0.010 | 0.41 | 20 | 0.00% | -4.76% | ― | 18 Juni 2025 | |
Novartis Mini Future mit ISIN code: CH1436551159 | Novartis | Mini Future | Short | 99.26 | 95 | 0.72 | 0.080 | 0.8 | 10 | 0.00% | -8.86% | -30.77% | 3 Apr. 2025 | |
Novartis Constant Leverage mit ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 95 | 13.45 | 0.330 | 13.78 | 1 | -11.86% | -5.28% | 13.60% | 12 Mai 2025 | |
Novartis Constant Leverage mit ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 95 | 8.33 | 0.080 | 8.41 | 1 | -4.25% | -1.77% | 6.11% | 13 Okt. 2023 | |
Novartis Constant Leverage mit ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 95 | 0.74 | 0.030 | 0.77 | 1 | -10.84% | -5.13% | 10.45% | 13 Okt. 2023 | |
Novartis Constant Leverage mit ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 95 | 5.12 | 0.060 | 5.18 | 1 | -6.06% | -2.48% | 8.94% | 13 Okt. 2023 | |
Novartis Constant Leverage mit ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 95 | 2.33 | 0.040 | 2.37 | 1 | -7.91% | -3.32% | 10.95% | 13 Okt. 2023 | |
Novartis Constant Leverage mit ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 95 | 4.72 | 0.100 | 4.82 | 1 | 8.01% | -1.26% | -33.61% | 12 Mai 2025 | |
Novartis Constant Leverage mit ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 95 | 1.16 | 0.030 | 1.19 | 1 | 2.65% | -1.69% | -17.14% | 13 Okt. 2023 | |
Novartis Constant Leverage mit ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 95 | 2.97 | 0.030 | 3 | 1 | 2.41% | -0.67% | -11.08% | 13 Okt. 2023 | |
Novartis Constant Leverage mit ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 95 | 5.49 | 0.110 | 5.6 | 1 | 6.40% | -1.26% | -28.14% | 12 Mai 2025 | |
Novartis Constant Leverage mit ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 95 | 0.36 | 0.030 | 0.39 | 1 | -2.70% | -7.69% | -26.53% | 13 Okt. 2023 | |
Novartis Knock-Out Warrant (open end) mit ISIN code: CH1452885275 | Novartis | Knock-Out Warrant (open end) | Call | 94.226 | 95 | 0.11 | ― | ― | 10 | -59.26% | -47.62% | ― | 6 Juni 2025 | |
Novartis Knock-Out Warrant (open end) mit ISIN code: CH1452878171 | Novartis | Knock-Out Warrant (open end) | Call | 92.327 | 95 | 0.3 | 0.080 | 0.38 | 10 | -34.78% | -25.00% | ― | 28 Mai 2025 | |
Novartis Knock-Out Warrant (open end) mit ISIN code: CH1452872554 | Novartis | Knock-Out Warrant (open end) | Call | 90.389 | 95 | 0.49 | 0.080 | 0.57 | 10 | -24.62% | -16.95% | 25.64% | 22 Mai 2025 | |
Novartis Knock-Out Warrant (open end) mit ISIN code: CH1452867265 | Novartis | Knock-Out Warrant (open end) | Call | 88.414 | 95 | 0.69 | 0.080 | 0.77 | 10 | -18.82% | -12.66% | 16.95% | 19 Mai 2025 | |
Novartis Knock-Out Warrant (open end) mit ISIN code: CH1441359291 | Novartis | Knock-Out Warrant (open end) | Call | 86.769 | 95 | 0.85 | 0.080 | 0.93 | 10 | -15.84% | -10.53% | 11.84% | 16 Apr. 2025 | |
Novartis Knock-Out Warrant (open end) mit ISIN code: CH1436576537 | Novartis | Knock-Out Warrant (open end) | Call | 84.762 | 95 | 1.05 | 0.080 | 1.13 | 10 | -13.22% | -8.70% | 9.38% | 15 Apr. 2025 | |
Novartis Knock-Out Warrant (open end) mit ISIN code: CH1436573724 | Novartis | Knock-Out Warrant (open end) | Call | 82.786 | 95 | 1.25 | 0.080 | 1.33 | 10 | -11.35% | -7.41% | 7.76% | 11 Apr. 2025 |
Bei den Preisen der Basiswerte handelt es sich nicht um real-time Preise; d.h. die Preise können aufgrund von rechtsverbindlichen Vorschriften des Datenlieferanten verzögert sein. Eine mögliche Konsequenz ist, dass der Produktpreis erheblich von dem von Ihnen aufgrund des abgebildeten Basiswert Preises erwarteten Produktpreises abweicht.